Physio CKI partners with Kapital 1852 to implement its growth plans
Livingstone has advised the shareholders of Physio CKI Beteiligungs GmbH on the sale of a majority stake to Kapital 1852. The fast-growing Physio CKI Group brings Kapital 1852 on board, a growth partner set to support the further rollout of the established practice concept and regional expansion. Founder and managing partner Chaled Qarizada retains a significant stake in the company and continues to lead the group as CEO.
The fund Kapital 1852 SCS SICAV-SIF Equity Invest IV “MidCapPlus”, managed by the investment company Kapital 1852 Beratungs GmbH (“Kapital 1852”), has acquired a majority stake in Physio CKI Praxisgruppe (“Physio CKI”) as part of a combined succession plan and expansion financing. The collaboration aims to expand the Group’s proven practice concept to additional locations in the Rhine-Sieg and Cologne-Bonn metropolitan areas in Germany and strengthen healthcare in the region. Investments in the company’s digitalization are intended to make the offering more accessible and improve the patient experience.
Physio CKI, based in Bonn, is a fast-growing physiotherapy practice group that operates six practices in the Rhine-Sieg/Cologne-Bonn metropolitan area and is one of the largest regional market players just a few years after its founding. The practice group employs more than 100 professionals, with over 70 percent working in therapy and considers itself a partner to its patients’ therapy, well-being, and wellness. Their practice concept features quick appointment availability, a stable therapist-patient relationship, a focus on individual patient needs, and a modern practice atmosphere. A high percentage of long-term patient relationships reflects the success of the concept.
“With Kapital 1852, we have found a partner with whom we can jointly take the next step in expanding our healthcare offering. Together, we are looking to grow the regional availability of physiotherapy treatments and consultations,” said Chaled Qarizada, co-founder and managing director of Physio CKI. “Throughout the preparation and implementation of the transaction, my partner and I were given all the support we needed by Livingstone’s healthcare team. During the extensive preparation of the transaction and the entire M&A process, we could always rely on the competent support of Christian Grandin, Philip Dorsemagen, and Felix Baust and achieved a very good negotiation outcome with our new partner.”
“We were impressed by Physio CKI’s practice concept and annual growth. The practice group puts people at the center of every treatment while operating with efficient processes. We are excited to support Physio CKI as they continue to grow, making their therapy services available to as much of the population as possible,” said Sebastian Wilde, Partner at Kapital 1852.
Christian Grandin, Managing Partner at Livingstone, said: “Assisting Physio CKI Group in its search for a partner to continue its impressive growth story was an exciting and complex advisory mandate. We had the opportunity to accompany the restructuring of a heterogeneous group and the creation of a growth plan parallel to the search for an investor. As part of the pleasant cooperation with the founders of Physio CKI, we were able to contribute our in-depth expertise in the healthcare sector and bring the project to a successful conclusion.”
This marks the 15th successful transaction by Livingstone’s Healthcare team in the ongoing fiscal year 2023, following, among others, the three successful sales for Centers for Autism & Related Disorders, LLC, the financing and acquisition of CAM Bioceramics B.V. by SHS Capital and the merger of Weil Foot & Ankle with Balance Health.
WE ARE Unrelenting Advocates
We know our trade - and don't just sell figures. We develop a convincing story for your sale, which brings together all the essential aspects into a coherent overall pictureWE ARE Unrelenting Advocates
We know our trade - and don't just sell figures. We develop a convincing story for your sale, which brings together all the essential aspects into a coherent overall pictureWE ARE Unrelenting Advocates
We know our trade - and don't just sell figures. We develop a convincing story for your sale, which brings together all the essential aspects into a coherent overall picture
- "Throughout the preparation and implementation of the transaction, my partner and I were given all the support we needed by Livingstone’s healthcare team. During the extensive preparation of the transaction and the entire M&A process, we could always rely on the competent support of Christian Grandin, Philip Dorsemagen, and Felix Baust and achieved a very good negotiation outcome with our new partner."Chaled Qarizada, co-founder and managing director, Physio CKI Beteiligungs GmbH
- "We were impressed by Physio CKI’s practice concept and annual growth. The practice group puts people at the center of every treatment while operating with efficient processes. We are excited to support Physio CKI as they continue to grow, making their therapy services available to as much of the population as possible."Sebastian Wilde, Partner, Kapital 1852
- Christian Grandin
Managing Partner Düsseldorf
"Assisting Physio CKI Group in its search for a partner to continue its impressive growth story was an exciting and complex advisory mandate. We had the opportunity to accompany the restructuring of a heterogeneous group and the creation of a growth plan parallel to the search for an investor. As part of the pleasant cooperation with the founders of Physio CKI, we were able to contribute our in-depth expertise in the healthcare sector and bring the project to a successful conclusion."
Key Transaction Team
Additional Insights
- Livingstone Advises Centers for Autism & Related DisordersLivingstone is pleased to announce three successful sales for Centers for Autism & Related Disorders, LLC. With 130 centers across 13 states and approximately 2,500 employees and healthcare professionals supporting its over 3,500 patients, CARD is one of the largest autism therapy service providers
- Livingstone Benelux advised SHS Capital on the acquisition of CAM BioceramicsLivingstone is pleased to announce the firm’s Benelux team has advised SHS Capital on the financing and acquisition of CAM Bioceramics B.V. (CAM or the Company). Livingstone acted as exclusive Debt and Buy-side advisor to SHS. Transaction terms were not disclosed. CAM is a leading global...
- Livingstone advises neoplas med’s series B financing roundLivingstone’s healthcare team in Düsseldorf has continued its advisory for neoplas med GmbH and its second funding round. Niterra (formerly NGK Spark Plug Co., LTD) expands its partnership with the medtech company through a growth investment in partnership with Pegasus Technology Ventures. The...
- Evidia expands its presence in northern Germany with Förde-RadiologicumLivingstone has advised Evidia, a merger of Meine Radiologie Holding and blikk Holding, on the acquisition of the Förde-Radiologicum in Kiel.